As the apoptosis pathway contains both anti- (e.g. BCL2) as well as pro- (e.g. BID) -apoptotic genes [27] we examined expression of both sets revealing that generally anti-apoptotic genes are higher expressed in AML, but also in normal progenitors (Figure 3E). This evidence concerns the gene BCL2 and acute myeloid leukemia.